Targeting the JAK2/STAT3 axis in Alzheimer's disease

Author： Chiba Tomohiro Yamada Marina Aiso Sadakazu

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.10, 2009-10, pp. : 1155-1167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib

By Derenzini Enrico

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 775-785

Informa Healthcare

Access to resources Recommend Favorite

Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 71-77

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting JAK2 in the therapy of myeloproliferative neoplasms

By Reddy Mamatha M Deshpande Anagha Sattler Martin

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 313-324

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tau Protein in Alzheimer's Disease

By Gong Cheng-Xin Grundke-Iqbal Inge Iqbal Khalid

Drugs & Aging, Vol. 27, Iss. 5, 2010-05 ,pp. : 351-365

Adis International

Access to resources Recommend Favorite

Targeting ubiquilin-1 in Alzheimer's disease

By Takalo Mari

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 795-810

Informa Healthcare

Access to resources Recommend Favorite